Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | CCNC | P24863 | 1/20 | 0.38 |
| ▸ | CDK8 | P49336 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 4/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31428394 | 0.90 | RAB9A (0.39) | RAB9ANPC1CCNCCDK8HPGD | |
| SCHEMBL31428719 | 0.84 | PDCD1 (0.35) | RAB9ANPC1HPGDHSD17B10KDM4E | |
| SCHEMBL31428604 | 0.82 | CCNC (0.43) | RAB9ANPC1CCNCCDK8HPGD | |
| SCHEMBL31428987 | 0.77 | RIPK1 (0.44) | HPGDGRM2ERN1KDM4EALDH1A1 | |
| SCHEMBL31428954 | 0.76 | CCNC (0.44) | RAB9ANPC1CCNCCDK8HPGD | |
| SCHEMBL31428737 | 0.76 | NPC1 (0.37) | RAB9ANPC1HPGDHSD17B10KDM4E | |
| SCHEMBL31428711 | 0.74 | GRM2 (0.51) | HPGDGRM2ERN1KDM4EALDH1A1 | |
| SCHEMBL31428649 | 0.73 | CNR2 (0.46) | RAB9ANPC1CCNCCDK8HPGD | |
| SCHEMBL24975793 | 0.73 | GRM2 (0.47) | RAB9ANPC1CCNCCDK8HPGD | |
| SCHEMBL31428712 | 0.73 | GRM2 (0.49) | CCNCCDK8HPGDGRM2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | BRAF, RAF1, NRAS | RAB9A 67/4885NPC1 3237/4885CCNC 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.